Nasdaq
RNAC
Cartesian Therapeutics, Inc.
- Health Care
- Listed 2016
- 1 day
- +4.9%
- 1 month
- −12.8%
- 1 year
- −22.3%
$8.76 · Mkt cap $257M
At the 6 Aug 2026 close
Nasdaq
Cartesian Therapeutics, Inc.
$8.76 · Mkt cap $257M
At the 6 Aug 2026 close
Cartesian Therapeutics, Inc. trades under the ticker RNAC on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2016. Its market capitalisation is $257M. The last closing price was $8.76, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −22.3%, and −12.8% over the past month. Returns are price returns and exclude dividends.
This page exists because RNAC is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.